Abbott ABT, a global leader in healthcare solutions, recently achieved a significant milestone with the FDA approval of its cutting-edge Alinity h-series hematology system. This approval is poised to ...
ABBOTT PARK, Ill., March 5, 2019 /PRNewswire/ -- Abbott (NYSE: ABT) today announced that Regional Medical Laboratory, Inc. (RML) will use the company's most advanced technology, Alinity ci-series, to ...
ABBOTT PARK, Ill., June 14, 2017 — Abbott announced today that the Alinity hq analyzer for hematology is now CE Marked and available in Europe and other countries that recognize CE Mark. The analyzer ...
Abbott Laboratories, Inc. ABT recently announced the receipt of the FDA approval for the Alinity i laboratory traumatic brain injury (TBI) blood test. This will be the first commercially available TBI ...
Alinity, a family of next-generation clinical chemistry and immunoassay diagnostics from Abbott Laboratories (NYSE:ABT) is now being offered in Europe and other countries that distinguish the CE mark.
North West London Pathology (NWLP), hosted by Imperial College Healthcare NHS Trust, and Abbott announced that they signed a $252 million managed equipment services contract for the supply of all ...